R&D Investment in Demonstration Testing of the ケミレス・ハイシス Product and Technology
First written in FY2016. 19 of 28 entries say "Restated". Latest entry: FY2026-H1.
47 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「The Group's total R&D expenses for the interim consolidated period were ¥44.296 million. There were no material changes in the Group's R&D activities during the period.」
While stating that there had been no material changes in its R&D activities, the Group disclosed total R&D expenses of ¥44.296 million for the interim consolidated period. - FY2025-H1RestatedAnnual report
「The Group's total R&D expenses for the interim consolidated period were ¥19.048 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed total R&D expenses of ¥19.048 million for the interim consolidated period. - FY2024AdvancedAnnual report
「The Group's R&D activities by segment during the fiscal year were as follows: R&D expenses were ¥33.337 million for the water-related business and ¥4.167 million for the energy-related business, for a total of ¥37.505 million.」
The Group specified its R&D activities, including Chemiless treatment of cleaning wastewater, acclimatization technology, portable water treatment equipment, powdered activated carbon dosing equipment, water intake product improvements, and new internal process certifications, and recorded R&D expenses of ¥37.505 million. - FY2024-Q3RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the third quarter were ¥24.849 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed total R&D expenses of ¥24.849 million for the cumulative period through the third quarter. - FY2024-Q2RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the second quarter were ¥17.558 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥17.558 million for the cumulative consolidated period through the second quarter. - FY2024-Q1RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the first quarter were ¥8.867 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥8.867 million for the cumulative period through the first quarter. - FY2023AdvancedAnnual report
「The Group's R&D activities by segment during the fiscal year were as follows: R&D expenses were ¥31.256 million for the water-related business and ¥3.543 million for the energy-related business, for a total of ¥34.799 million.」
The Group disclosed total R&D expenses of ¥34.799 million and presented specific development initiatives, including Chemiless treatment of cleaning wastewater, acclimatization technology, portable equipment, Air-Sys improvements, water intake product improvements, and new manufacturing certification for the energy-related business. - FY2023-Q3RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the third quarter were ¥21.013 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed total R&D expenses of ¥21.013 million for the cumulative period through the third quarter. - FY2023-Q2RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the second quarter were ¥15.546 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed total R&D expenses of ¥15.546 million for the cumulative period through the second quarter. - FY2023-Q1RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the first quarter were ¥7.176 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed total R&D expenses of ¥7.176 million for the first quarter. - FY2022AdvancedAnnual report
「① Expanding Chemiless applications: The Group is expanding the system's application range by deliberately combining it with chemical dosing for water sources that previously could not be treated, without compromising the system's strengths. ② Treatment of high-concentration ammonia nitrogen: Conventional treatment of ammonia nitrogen requires large quantities of chemicals, increasing treatment costs. The Group is working to improve its products and make them more competitive than conventional products through improvements to Chemiless technology, including improvements to dissolved oxygen supply methods.」
The Group presented specific R&D initiatives for Chemiless, including expanding its application range through combination with chemical dosing, treating high-concentration ammonia nitrogen, and improving dissolved oxygen supply methods. - FY2022-Q2RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the second quarter were ¥13.409 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥13.409 million for the cumulative period through the second quarter. - FY2021-Q3RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the third quarter were ¥18.232 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed total R&D expenses of ¥18.232 million for the cumulative period through the third quarter. - FY2021-Q2RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the second quarter were ¥14.537 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥14.537 million for the cumulative period through the second quarter. - FY2021-Q1RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the first quarter were ¥7.110 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥7.110 million for the quarter. - FY2020-Q3RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the third quarter were ¥27.580 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥27.580 million. - FY2020-Q2RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the second quarter were ¥20.204 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities and disclosed total R&D expenses of ¥20.204 million for the cumulative period through the second quarter. - FY2019AdvancedAnnual report
「The Group's R&D expenses for the fiscal year related to the water-related business and totaled ¥29.312 million.」
The Group continued R&D in the water-related business and presented specific development initiatives, including Chemiless treatment of special wastewater, overseas demonstrations and equipment improvements, and Air-Sys deliveries and performance improvements. R&D expenses were ¥29.312 million. - FY2019-Q3AdvancedAnnual report
「In Vietnam, following the introduction of Chemiless at a private company, a joint demonstration project with a local company was conducted to introduce it at a water treatment plant. The results confirmed Chemiless's advantages, leading to an order.」
Following the joint demonstration project in Vietnam, Chemiless's advantages were recognized and resulted in an order. The Group also stated that R&D expenses for the cumulative consolidated period through the third quarter were ¥20.548 million and that there had been no material changes in its R&D activities. - FY2019-Q2AdvancedAnnual report
「In Vietnam, the company established a track record of introducing its products at a private company, followed by a decision to conduct a joint demonstration project with a local company aimed at introducing them at a water treatment plant.」
For its water treatment technology demonstration activities, the Group announced its decision to conduct a new joint demonstration project in Vietnam aimed at introducing the technology at a water treatment plant. - FY2018AdvancedAnnual report
「During the fiscal year, the Group's R&D activities used core technologies it has developed to date, including screen manufacturing and processing technology, solid-liquid separation technology using screens, water intake technologies such as sand control, and water treatment technologies. The Group worked to improve existing products and develop proprietary technologies and new products in the fields of groundwater and seawater intake and water treatment. R&D expenses for the fiscal year related to the water-related business and totaled ¥24.173 million.」
While maintaining its basic R&D policy, the Group presented specific development initiatives, including radium removal by Chemiless, Air-Sys for municipal water supply applications, and the introduction of Hi-Sys into commercial operations. - FY2018-Q3RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the third quarter were ¥17.385 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities. Total R&D expenses for the cumulative consolidated period through the third quarter were ¥17.385 million. - FY2018-Q2RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the second quarter were ¥13.078 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities. Total R&D expenses for the cumulative consolidated period through the second quarter were ¥13.078 million. - FY2018-Q1RestatedAnnual report
「The Group's total R&D expenses for the cumulative consolidated period through the first quarter were ¥6.720 million. There were no material changes in the Group's R&D activities during the period.」
The Group reconfirmed that there had been no material changes in its R&D activities. Total R&D expenses for the quarter were ¥6.720 million. - FY2017-Q3RestatedAnnual report
「There were no significant changes in the status of research and development activities of our group during the cumulative third quarter consolidated accounting period.」
The Group reconfirmed that there had been no material changes in its R&D activities. Total R&D expenses for the cumulative consolidated period through the third quarter were ¥28.187 million. - FY2017-Q2RestatedAnnual report
「There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The Group stated that there had been no material changes in its R&D activities and maintained its existing policy. - FY2017-Q1AdvancedAnnual report
「The Group is conducting demonstration testing to establish the removal of additional substances by Chemiless.」
Chemiless has progressed from conventional arsenic removal to demonstration testing to verify the removal of additional substances. R&D expenses for the quarter were ¥10.156 million. - FY2016First statedAnnual report
「The Group will promote product R&D through demonstration testing of Chemiless and Hi-Sys and build its technological capabilities for future growth by investing management resources in medium-term product development. Total R&D expenses for the fiscal year were ¥64.603 million.」
The Group uses demonstration testing as a means of conducting R&D and product development, and has disclosed R&D expenses for the fiscal year.